Africa (WHO region) vs Comoros: HIV-positive TB patients on ART (antiretroviral therapy)
Africa (WHO region)
96.0%
in 2024
Comoros
100.0%
in 2023
Africa (WHO region) rank
2nd
Comoros rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Africa (WHO region)
- Comoros
How they compare
Comoros currently reports 100.0% against 96.0% in Africa (WHO region), a difference of 4.0%.
The two have swapped places 2 times across 11 shared years of data; in 2005 it was Comoros ahead.
Africa (WHO region) ranks 2nd and Comoros ranks 1st of 11 groups.
Across the 3 decades both report, Africa (WHO region) averaged higher in 1 and Comoros in 2.
Head to head by decade
| Decade | Africa (WHO region) | Comoros | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 29.0% | 100.0% | 71.0% | Comoros |
| 2010s | 73.0% | 100.0% | 27.0% | Comoros |
| 2020s | 92.5% | 91.8% | 0.8% | Africa (WHO region) |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Africa (WHO region) or Comoros?
- Comoros, at 100.0% against 96.0% in Africa (WHO region) as of 2023.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Africa (WHO region) and Comoros?
- 4.0%, with Comoros ahead.
- How many years of comparable data are there for Africa (WHO region) and Comoros?
- 11 years are reported by both, from 2005 to 2023.
- How do Africa (WHO region) and Comoros rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Africa (WHO region) ranks 2nd and Comoros ranks 1st of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.